United States Department of Defense
1400 Defense Pentagon, Room 1E757
29 articles with United States Department of Defense
Ellume Announces $231.8 Million Agreement with the U.S. Government to Scale Up Production of COVID-19 Home Tests
The investment will support the establishment of Ellume’s first U.S. manufacturing facility, increasing Ellume’s global production capacity by 500,000+ tests per day once completed
Just - Evotec Biologics Expands Contract with the Department of Defense for Manufacturing of Monoclonal Antibodies
Evotec SE announced that the U.S. Department of Defense awarded its Seattle, Washington-based subsidiary, Just - Evotec Biologics, Inc., an agreement worth $28.6 million for the production of monoclonal antibodies for use in the development of a treatment and/or prophylaxis for COVID-19.
BIO 300 will be tested as a post-infection prophylactic to mitigate pulmonary inflammation leading to COVID-19 complications
Cue's Molecular, Point-of-Care COVID-19 Tests Now Available in 10 States Under Health and Human Services and Department of Defense Pilot Program
Cue Health Inc. announced that its molecular, point-of-care COVID-19 Tests are being distributed to five additional states, including Colorado, Minnesota, Pennsylvania, Rhode Island and Utah, as part of the joint $481 million program with the U.S. Department of Health and Human Services and the Department of Defense.
The U.S. Department of Defense awarded Moderna a contract worth $1,966,598,000 for an additional 100 million doses of its COVID-19 vaccine.
BioXcel Therapeutics Announces Grant by U.S. Department of Defense to Evaluate BXCL501 in Patients Suffering from PTSD
Grant will support clinical studies in patients with post-traumatic stress disorder related to alcohol and substance abuse
Humanigen Announces Cooperative Research and Development Agreement with the Department of Defense to Develop Lenzilumab for COVID-19
The Cooperative Research and Development Agreement (CRADA) with the Department of Defense (DoD) in support of Operation Warp Speed (OWS) aims to improve the availability of lenzilumab for patients with COVID-19 Humanigen’s development efforts complemented by full-scale, integrated team of OWS leading experts and U.S. Government decision makers dedicated to advancing lenzilumab ahead of a potential Emergency Use Authorization (EUA) submission
Department of Defense Awards Ology Bioservices Contract to Manufacture and Test Novel Live Attenuated Tularemia Vaccine Candidate
Ology Bioservices Inc. (Ology Bio), a biologics contract development and manufacturing organization (CDMO), announced today that the Department of Defense (DOD), through the Joint Science and Technology Office of the Defense Threat Reduction Agency (DTRA), has awarded the company with a contract to manufacture a novel live attenuated tularemia vaccine. The contract value is $6.3 million. The vaccine candidate ATI-1701
Partner Therapeutics Announces $35 Million Contract with U.S. Department of Defense for Advanced Development and Emergency Use of Leukine® (rhuGM-CSF) for COVID-19 Acute Hypoxemic Respiratory Failure (AHRF)
Funding will support two randomized, multi-center clinical trials in COVID-19 patients, expansion of manufacturing capacity and potential Emergency Use Authorization filing
DOD to Fund a Multi-Center Randomized Clinical Trial of COVID-19 Treatment With ExThera’s Seraph 100 Blood Filter
After encouraging preliminary results in the treatment of critically-ill COVID-19 patients at a military hospital in the United States and fourteen other hospitals in Europe, the Department of Defense has selected the Seraph®100 Microbind® Affinity Blood Filter (Seraph 100) as one of its main interventions in a pivotal, US-based randomized controlled trial. Financial support for the multi-center trial will be provided
“We are genuinely honored at the opportunity to protect our military personnel and their families who have devoted themselves to the needs of U.S. citizens and others worldwide,” said Stanley C. Erck, president and chief executive officer of Novavax.
XENDEE Corporation has signed a contract with the US Department of Defense (DoD) to develop the Standardized Platform to Guide Rapid and Repeatable Modelling and Design of Secure and Resilient DoD Microgrids globally. XENDEE has been tasked to deliver design solutions that enhance energy reliability, while providing new services such as the ability to safely ride-out prolonged utility power outages and sustain mission critica
physIQ, Department of Defense, and The Henry M. Jackson Foundation for The Advancement of Military Medicine Partner to Deploy Continuous Remote Monitoring Platform to Study COVID-19
This DOD-funded initiative will assess the role of home-based continuous biosensor data and AI analytics in addressing the global COVID-19 crisis.
Company will increase U.S. production from 35 million per month to more than 95 million per month by October.
MRIGlobal's Athena, state-of-the-art, next generation mobile laboratories will augment U.S. Army's ability to rapidly test for COVID-19
The National Center for Manufacturing Sciences (NCMS) is pleased to announce a new partnership with the Department of Defense (DOD) and the Federal Emergency Management Agency (FEMA) to support the critical shortage of medical equipment and supplies. Tapping into our significant network of American manufacturers, and working al
With Superbugs and Antibiotic Resistance on the Rise, VA Facilities Make Infection Prevention a Priority
Geo-Med & Xenex Enhance Veteran Safety with Infection Prevention Programs Utilizing LightStrike Germ-Zapping Robots
Vital Signs Monitoring Systems and Cardiology Technology Meet Stringent Data Security Standards
Hemopure® to be evaluated in groundbreaking clinical study of trauma patients in the prehospital setting, sponsored by the United States Department of Defense, and coordinated by Stellenbosch University
Patient enrollment expected to commence in mid 2019
As we end October and head into November, the Food and Drug Administration (FDA) continues its work. This upcoming week has several PDUFA action dates for drug applications. Here’s a look.